Human epidermal growth factor receptor 2 (HER2), a protein associated with the rapid growth of breast cancer, is another TAA for which targeted immunotherapies have been particularly effective, albeit with high rates of relapse or disease progression [68]. This evidence concerns the gene ERBB2 and breast cancer.